Brief: Astrazeneca Pharma India Received Permission To Import For Sale And Distribution Of Tremelimumab (Imjudo)
01/06/2023 13:50
June 1 (Reuters) - Astrazeneca Pharma India Ltd
ASTR.NS :
* ASTRAZENECA PHARMA INDIA LTD - RECEIVED PERMISSION TO
IMPORT FOR
SALE AND DISTRIBUTION OF TREMELIMUMAB (IMJUDO) CONCENTRATE FOR
SOLUTION
* ASTRAZENECA PHARMA INDIA LTD - PERMISSION FROM
DIRECTORATE
GENERAL OF HEALTH SERVICES, GOVERNMENT OF INDIA
Source text for Eikon: ID:nBSE54YVpn
Further company coverage: ASTR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication